Skip to content
MS
unreviewed

Phosphoglucomutase

3 reactions · 3 pathways

What it does, reaction by reaction

3 reactions

Galactose Metabolism Carbohydrate Metabolism · Cytosol

step 6 Reversible

Glucose-1-phosphate ↔ glucose-6-phosphate

Converts Glucose-1-phosphate into Glucose-6-phosphate

Notes

Phosphoglucomutase reversibly forms glucose-6-phosphate through a glucose-1,6-bisphosphate intermediate. The product can enter glycolysis, glycogenesis, or, in liver, be converted to free glucose by glucose-6-phosphatase.

Glycogenesis (Glycogen Synthesis) Carbohydrate Metabolism · Cytosol (glycogen particle)

step 2 Reversible

Glucose-6-phosphate ↔ glucose-1-phosphate

Converts Glucose-6-phosphate into Glucose-1-phosphate

Notes

Phosphoglucomutase reversibly transfers the phosphate through a glucose-1,6-bisphosphate intermediate; a catalytic phosphoserine is primed by glucose-1,6-bisphosphate. This reaction directs glucose carbon toward activated-sugar formation.

Glycogenolysis (Glycogen Breakdown) Carbohydrate Metabolism · Cytosol + ER (liver)

step 4 Reversible

Glucose-1-phosphate ↔ glucose-6-phosphate

Converts Glucose-1-phosphate into Glucose-6-phosphate

Notes

Cytosolic phosphoglucomutase reversibly transfers the phosphate via glucose-1,6-bisphosphate. In muscle, glucose-6-phosphate enters glycolysis; in liver it is prepared for export.

Showing all 3 reactions.

What accelerates and inhibits it

Regulation is pathway-specific, so each context is listed separately

0 entries

No regulation recorded for this enzyme in the source documents.

Recent literature

Europe PMC · from cache · sorted by publication date

  1. 1
    Impact of leucine-rich diet on placenta's proteomic and metabolomic profiles of pregnant tumor-bearing rats.

    Dos Santos IF, Salgado CM, Carregari VC, Dos Santos RW, de Souza DM, Viana LR, Gomes-Marcondes MCC. · 2026-05-14

    open access unreviewed
  2. 2
    Efficient whole-cell biotransformation for gastrodin production via glycosyltransferase engineering and process optimization.

    Wang X, Zhang J, Li T, Wang F, Wang Z, Li X. · 2026-04-06

    open access unreviewed
  3. 3
    Stepwise phage resistance and collateral phage susceptibility in <i>Klebsiella pneumoniae</i>.

    Yin X, Feng Y, Luo H, Fang Q, Yu J, McNally A, Zong Z. · 2026-05-29

    cited 1× open access unreviewed
  4. 4
    An update on regulation of the polymodal TRPV4 channel by protein phosphorylation.

    Parthasarathy A, Zhang DX. · 2026-01-19

    open access unreviewed
  5. 5
    Small regulatory RNAs mediated regulation of virulence and host-pathogen interaction in the Gram-negative ESKAPE pathogens.

    Li L, Zhang Z, Zhu H, Cui K, Song X, Wang Z, Chen L, Yu Z, Zhang W, Sun H, Yu Z, Duan Y, Li M. · 2025-12-18

    open access unreviewed
  6. 6
    High-level biosynthesis of gastrodin in engineered Escherichia coli.

    Ge L, Jia R, Xu W, Xia Y, Pei J. · 2026-06-27

    unreviewed
  7. 7
    Structure-coevolution dual-guided engineering of C-glycosyltransferase enables high-level biosynthesis of vitexin in <i>Yarrowia lipolytica</i>.

    Shi CQ, Chen YJ, Yang WL, Zheng S, Cai R, Hou J, Wang DQ, Sheng JZ. · 2026-03-09

    open access unreviewed
  8. 8
    Enzyme promiscuity-driven co-production of flavonoid 7-<i>O</i>-glycosides in engineered <i>Saccharomyces cerevisiae</i>.

    Tan X, Zuo S, Hu F, Xiao Z, Wang Y, Zhang S, Lu Q, Zhao Y, Chen J, Fan L, Liu J, Shan Y. · 2026-02-12

    cited 1× open access unreviewed
  9. 9
  10. 10
    The MagMa Study: Quantum Magnetocardiography in Cardiomyopathy.

    Suwalski P, Wilke F, Latinova E, Paci G, Satilmis G, Klingel K, Kelle S, Weiner J, Beule D, Lüscher TF, Landm… · 2026-08-01

    unreviewed

External claims. These come from an index outside this database and are not checked against it. Treat them as leads.